Genmab(DE:GE91)
€46.00-0.60 (-1.29%)
DE:GE91
Genmab earnings date
€46.00
At close:-0.60 (-1.29%)
Genmab (GE91) Q2 2023 Earnings Report
3 Followers
DE:GE91 Q2 2023 EPS Results
- Actual EPS
- EUR 0.28
- Consensus EPS
- EUR 0.26
- Beat/Miss
- Beat by +EUR 0.01
- One Year Ago EPS
- EUR 0.36
DE:GE91 Q2 2023 Revenue Results
- Actual Revenue
- EUR 557.94M
- Expected Revenue
- EUR 546.87M
- Beat/Miss
- Beat by +EUR 11.07M
- YoY Revenue Growth
- +35.39%
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 08/03/2023
- Time
- Before Open
- Conference Call
- Thursday, August 3, 2023
DE:GE91 Upcoming Earnings
Genmab's next earnings date is estimated for February 24, 2027, based on past reporting schedules.
Q2 2023 Earnings Call Audio
DE:GE91 Q2 2023 Earnings Call
0:00 / 0:00
Q2 2023 Earnings Slide Deck
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:GE91 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 24, 2027 | 2026 (Q4) | 0.19- | 0.05 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | 0.320.50 | 0.59 | -14.71% (-0.09) | |
| Aug 06, 2026 | 2026 (Q2) | 0.320.45 | 0.49 | -9.41% (-0.05) | |
| May 07, 2026 | 2026 (Q1) | 0.140.08 | 0.28 | -72.79% (-0.20) | |
| Feb 17, 2026 | 2025 (Q4) | 0.260.05 | 0.77 | -94.12% (-0.73) | |
| Nov 10, 2025 | 2025 (Q3) | 0.440.59 | 0.26 | 125.09% (+0.33) | |
| Aug 07, 2025 | 2025 (Q2) | 0.360.49 | 0.29 | 70.98% (+0.20) | |
| May 08, 2025 | 2025 (Q1) | 0.210.28 | 0.27 | 4.45% (+0.01) | |
| Feb 12, 2025 | 2024 (Q4) | 0.340.77 | 0.13 | 512.23% (+0.65) | |
| Nov 06, 2024 | 2024 (Q3) | 0.280.26 | 0.42 | -38.15% (-0.16) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed


